In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone
Mazza, A., Fruci, B., Guzzi, P., D'Orrico, B., Malaguarnera, R., Veltri, P., Fava, A., Belfiore, A.Volume:
24
Language:
english
Journal:
Nutrition, Metabolism and Cardiovascular Diseases
DOI:
10.1016/j.numecd.2013.04.016
Date:
February, 2014
File:
PDF, 345 KB
english, 2014